ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC…

Subpotent drug

Date

2024-12-11

Country

United States

Brand

Accord Healthcare

Product

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC…

Classification

Class II

Units

USA Nationwide

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Accord Healthcare recalls

1. 2025-10-15
2. US
   Drugs & medicalClass II

   ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh,…

   Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

   FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USOfficial notice →
3. 2025-07-23
4. US
   Drugs & medicalClass II

   ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC…

   Subpotent Drug: Assay below the approved specification

   FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USAOfficial notice →
5. 2025-05-07
6. US
   Drugs & medicalClass II

   ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617,…

   Subpotent

   FDA · DrugACCORD HEALTHCARE, INC.Nationwide US.Official notice →
7. 2024-11-06
8. US
   Drugs & medicalClass II

   ACCORD HEALTHCARE, INC. recalls Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC: 16729-442-15,…

   CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

   FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USA and PROfficial notice →
9. 2024-10-23
10. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare…

    Failed Impurities/Degradation Specifications.

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide within the United States and PROfficial notice →
11. 2024-07-10
12. US
    Drugs & medicalClass III

    Accord Healthcare, Inc. recalls Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord Healthcare, Inc.,…

    Subpotent drug: out of specification results

    FDA · DrugAccord Healthcare, Inc.USA NationwideOfficial notice →

Other drugs & medical recalls in the United States

1. 2024-12-11
2. US
   Drugs & medicalClass I

   Boulla LLC recalls ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com

   Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

   FDA · DrugBoulla LLCNationwide within the United StatesOfficial notice →
3. US
   Drugs & medicalClass II

   American Regent, Inc. recalls Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use…

   Presence of Particulate Matter: Potential for glass delamination from the vials.

   FDA · DrugAmerican Regent, Inc.Nationwide in the USAOfficial notice →
4. US
   Drugs & medicalClass II

   Aurobindo Pharma USA Inc recalls Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only,…

   cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

   FDA · DrugAurobindo Pharma USA IncUSA NationwideOfficial notice →
5. 2024-12-04
6. US
   Drugs & medicalClass II

   Micro-X Ltd. recalls MICRO-X Rover Mobile X-ray System, # MXU-RV35

   Mobile x-ray system receiving/storage(operation) requirements to be followed: Temp:14 to 131(50 to 86) degrees F, RH:10% to 86%(30% to 60%) allow condensation dry time, Atmospheric Pressure:50kPa to 106 kPa(70kPa to…

   FDA · DeviceMicro-X Ltd.US: TX, PR, MD, CAOfficial notice →
7. US
   Drugs & medicalClass II

   Gauthier Biomedical, Inc. recalls TriALTIS TORQUE LIMITER, RATCHET, 11.3 Nm, Model Number 5161-00-5048 (G919509)

   An out of specification component may result in the device exhibiting torque output higher than the design specification.

   FDA · DeviceGauthier Biomedical, Inc.US Nationwide distribution in the state of MA.Official notice →
8. US
   Drugs & medicalClass II

   LivaNova Deutschland GmbH recalls Essenz HLM (Heart-Lung Machine), REF: 49-00-10, with Software

   Heart-Lung Machine GUI touchscreen may go dark for 10-15 seconds, safety/performance functions remain operational before reset, control maintained through backup control panel, but second reset may occur, may lead to…

   FDA · DeviceLivaNova Deutschland GmbHUS Nationwide distribution in the states of CA, VA, GA, IN, NJ, FL, CO, MS, NV.Official notice →